Authors retract two papers on Remicade following legal battles
A group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case. The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva … Continue reading Authors retract two papers on Remicade following legal battles